Viewing Study NCT00357994


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-02-24 @ 2:31 PM
Study NCT ID: NCT00357994
Status: COMPLETED
Last Update Posted: 2015-01-16
First Post: 2006-07-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
Sponsor: AbbVie (prior sponsor, Abbott)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Parkinson's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None carbidopa View
None levodopa-carbidopa View
None levodopa View
None levodopa/carbidopa suspension View
None dyskinesia View
None Duodopa View
None levodopa-carbidopa intestinal gel View
None Severe Motor Fluctuations View
None DUOPA View